ACHIEVE LIFE SCIENCES, INC. 4

Director/officer Richard Alistair Stewart received awards of 25,000 stock options at $6.18 and 16,700 RSUs from Achieve Life Sciences, Inc. on July 27, 2026.

On July 27, 2026, reporting person Richard Alistair Stewart of Achieve Life Sciences, Inc. received a grant of 25,000 stock options with an exercise price of $6.18 per share and 16,700 restricted stock units, both categorized as awards and not involving any open-market purchases or sales. The options and RSUs each vest 100% on the earlier of July 27, 2027 or the date immediately prior to the issuer’s 2027 annual meeting of stockholders, contingent on continued service. Following these grants, Stewart beneficially owns 41,700 shares or share equivalents (25,000 options and 16,700 RSUs) on a derivative/direct basis, representing routine equity-based compensation rather than a discretionary transaction in the open market.

Filing Facts

CIK

949858

Ticker

ACHV

Form

4

Source Type

fda

Accession

0001193125-26-324245

Alert Tier

5